BioRem (BRM) Stock Chart & Stock Price History C$2.05 0.00 (0.00%) As of 01:57 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesBuy This Stock BioRem Stock Price Performance The BioRem (BRM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 0.49%, with a year-to-date return of -32.79%. In the past month, the stock has decreased 15.64%, reflecting recent market activity. As of the latest close, BioRem traded at C$2.05 with a market cap of C$33.62 million and volume of 37,340 shares. Receive BRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.38%1 Month Performance-15.64%3 Month Performance+16.48%Year-To-Date Performance-32.79%1 Year Performance-0.49% BRM Stock Chart for Friday, August, 8, 2025 BRM Chart by TradingView BioRem Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025C$2.07C$2.05-0.97%C$2.10C$2.0437,340 shsC$33.62 million08/06/2025C$2.10C$2.07-1.43%C$2.14C$2.0723,071 shsC$33.94 million08/05/2025C$2.10C$2.10C$2.10C$2.045,915 shsC$34.44 million08/04/2025C$2.10C$2.10C$2.15C$2.0716,443 shsC$34.44 million08/01/2025C$2.16C$2.10-2.78%C$2.15C$2.0716,443 shsC$34.44 million07/31/2025C$2.07C$2.16+4.35%C$2.17C$2.0690,927 shsC$35.42 million07/30/2025C$2.08C$2.07-0.48%C$2.08C$2.067,628 shsC$33.94 million07/29/2025C$2.07C$2.08+0.48%C$2.11C$2.0529,675 shsC$34.11 million07/28/2025C$2.06C$2.07+0.49%C$2.13C$2.01184,935 shsC$33.94 million07/25/2025C$2.23C$2.06-7.62%C$2.22C$2.06108,530 shsC$33.78 million Get the Latest News and Ratings for BRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025C$2.22C$2.23+0.45%C$2.24C$2.205,320 shsC$36.57 million07/23/2025C$2.18C$2.22+1.83%C$2.33C$2.15288,072 shsC$36.40 million07/22/2025C$2.22C$2.18-1.80%C$2.21C$2.1839,000 shsC$35.75 million07/21/2025C$2.22C$2.22C$2.25C$2.223,100 shsC$36.40 million07/18/2025C$2.27C$2.22-2.20%C$2.26C$2.2243,596 shsC$36.40 million07/17/2025C$2.26C$2.27+0.44%C$2.31C$2.269,800 shsC$37.22 million07/16/2025C$2.34C$2.26-3.42%C$2.35C$2.2614,142 shsC$37.06 million07/15/2025C$2.45C$2.34-4.49%C$2.45C$2.34134,704 shsC$38.37 million07/14/2025C$2.37C$2.45+3.38%C$2.45C$2.30160,273 shsC$40.17 million07/11/2025C$2.27C$2.37+4.41%C$2.45C$2.23197,045 shsC$38.86 million07/10/2025C$2.33C$2.27-2.58%C$2.38C$2.25233,950 shsC$37.22 million07/09/2025C$2.43C$2.33-4.12%C$2.40C$2.339,177 shsC$38.21 million07/08/2025C$2.35C$2.43+3.40%C$2.47C$2.26188,600 shsC$39.85 million07/07/2025C$2.37C$2.35-0.84%C$2.42C$2.20188,179 shsC$38.53 million Related Companies Gear Energy Stock Chart Graphite One Stock Chart EQ Stock Chart Medicenna Therapeutics Stock Chart Canadian Gold Stock Chart CI Canadian Convertible Bond ETF Common Stock Chart Relevant Gold Stock Chart Ascendant Resources Stock Chart Niobay Metals Stock Chart Galore Resources Stock Chart Receive BRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:BRM) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
